Posted Dec. 13, 2011 at 7:24 a.m.

Premium Lock Oxygen Biotherapeutics to raise $7.5M in private placement

Published: 2011-12-13 07:24:10
Updated: 2011-12-13 07:24:10

OxyBio OxyBio

The funding follows a shakeup at Oxygen's executive offices and board. Former Chairman and CEO Chris Stern's positions at the company were terminated in August following an internal investigation that concluded Stern lied about his academic background and conducted undisclosed securities deals that he tried to cover up. Shortly afterward, two members of Oxygen's board of directors resigned after shareholders withheld their votes for the two directors....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders